Regression of hepatic adenomata after cessation of selective oestrogen receptor modulator.
Carswell
Kirstin A
KA
Department of Laparoscopic and Hepatobiliary Surgery, King's College Hospital, London, UK. kirstin.carswell@kch.nhs.uk
Belgaumkar
Ajay
A
Karani
John
J
Patel
Ameet G
AG
D018248:Adenoma, Liver Cell / Q000139:chemically induced* / Q000473:pathology*; D000368:Aged; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D020849:Raloxifene Hydrochloride / Q000009:adverse effects*; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects*
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride